Carrie Bourdow Email

CEO . Trevena

Current Roles

Employees:
40
Revenue:
$7.5M
About
Approximately 40% of modern medicinal products target GPCRs and GPCRs remain the largest class of targets currently under clinical evaluation. Currently marketed GPCR drugs suffer significant problems such as limited efficacy and undesirable adverse effects, which generally limit their overall use. Furthermore, there are many GPCRs linked to disease that cannot be translated into medicines because of specific target-related adverse effects. Trevena’s novel drug discovery approach combines a powerful, proprietary and efficient drug discovery platform with the Company’s extensive discovery and development experience to yield a rich pipeline of breakthrough medicines. Trevena’s drug discovery technology is based on the groundbreaking research from the laboratories of leading scientists in the field - Robert J. Lefkowitz, M.D. and Howard A. Rockman, M.D. of Duke University Medical Center.
Trevena Address
955 Chesterbrook Blvd
King of Prussia, PA
United States
Trevena Email

Past Companies

Trevena, Inc.Chief Executive Officer
Trevena, Inc.Chief Operating Officer
Trevena, Inc.Chief Commercial Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.